Bellevue Asset Management (Switzerland)’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$8.85M Sell
2015
Q3
$8.2M Buy
2015
Q2
$7.69M Sell
2015
Q1
$7.18M Buy